Sector revisions Bright Minds Biosciences Inc.
Equities
DRUG
CA10919W4056
Biotechnology & Medical Research
|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 113.39 CAD | -0.54% |
|
-10.67% | +2.68% |
| 01-09 | Bright Minds Biosciences Closes its US$175 Million Public Offering | MT |
| 01-09 | Bright Minds Biosciences Closes $175.1 Million Stock Offering | MT |
Main competitors
| 1m. Revenue rev. | 4m. EPS revision | 4m. Revenue rev. | 1y. EPS revision | 1y. Revenue rev. | Visibility | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|
| - | - | - | 4 | |||||
| 23 | ||||||||
| 20 | ||||||||
| 24 | ||||||||
| 22 | ||||||||
| 19 | ||||||||
| 12 | ||||||||
| 15 | ||||||||
| 16 | ||||||||
| 15 | ||||||||
| 12 | ||||||||
| 22 | ||||||||
| 14 | ||||||||
| 12 | ||||||||
| 13 | ||||||||
| Average | 16 | |||||||
| Weighted average by Cap. | 19 |
- Stock Market
- Equities
- DRUG Stock
- Sector Bright Minds Biosciences Inc.
- Sector revisions
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















